Zobrazeno 1 - 10
of 1 805
pro vyhledávání: '"vascular endothelial growth inhibitor"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Most pituitary tumors are considered benign adenomas, and only 0.1%–0.2% of them present metastasis and are defined as pituitary carcinomas (PCs). Refractory pituitary adenomas (PAs) lie between benign adenomas and true malignant PCs and are define
Externí odkaz:
https://doaj.org/article/8fe4900f61c6430098f966006066a7df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Guoji Yanke Zazhi, Vol 15, Iss 6, Pp 985-988 (2015)
AIM: To explore the effects of intravitreous injection on vascular endothelial growth inhibitor(VEGI)and its relative cytokines in vitreous and to investigate its role in the pathogenesis of proliferative diabetic retinopathy(PDR). METHODS: Fifty pat
Externí odkaz:
https://doaj.org/article/823f456fef8d4fd0848ce33d6927ecf9
Autor:
Dong Wang, Jianning Zhang, Shizhao Wang, Xiao Liu, Jianhua Xiong, Zhi-Song Zhang, Ye Liu, Shu Zhang, Lu-Yuan Li, Gui-Li Yang, Zengguang Wang, Huijie Wei
Publikováno v:
ASN Neuro, Vol 13 (2021)
ASN NEURO
ASN NEURO
Destabilization of blood vessels by the activities of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) following intracerebral hemorrhage (ICH) has been considered the main causes of aggravated secondary brain injury. He
Publikováno v:
Molecular and Clinical Oncology
Although the incidence of lung cancer is increasing worldwide, the molecular mechanisms for its tumorigenesis, progression and prognosis remain unknown. As a member of the tumor necrosis factor superfamily, vascular endothelial growth inhibitor (VEGI
Autor:
Huaiyuan Xiao, Jian-Wei Qi, Rongcai Jiang, Ye Liu, Gui-Li Yang, Huijie Wei, Zhenying Han, Shizhao Wang, Ting-Ting Qin, Zhi-Song Zhang, Li-Xia Xu, Lu-Yuan Li, Jianning Zhang, Jianhua Xiong
Publikováno v:
The FASEB Journal. 33:10505-10514
Hemangioblastoma (HB) is an abnormal intracranial buildup of blood vessels that exhibit a great potential for hemorrhage. Surgical options are limited, and few medications are available for treatment. We show here by immunohistochemical analysis that
Autor:
Zbigniew Kmieć, Jarek Kobiela, Dorota Żurawa-Janicka, Piotr M. Wierzbicki, Marta Cyman, Wojciech Makarewicz, Marek Guzek, Tomasz Jerzy Ślebioda, Marcin Stanisławowski
Publikováno v:
Digestive Diseases and Sciences
Background Tumor necrosis factor superfamily member 15 (TNFSF15) gene is involved in development of several cancers. It encodes two proteins: tumor necrosis factor ligand-related molecule 1A (TL1A) and vascular endothelial growth inhibitor 192 (VEGI-
Autor:
Lipei Liu, Xiaolin Wang, Lu-Yuan Li, Yuanli Chen, Xiaoxiao Yang, Yajun Duan, Chao Xue, Jihong Han, Peng Zeng, Dan Zhao, Jiaqi Li, Ke Feng, Zhisong Zhang
Publikováno v:
J Biol Chem
TNF ligand-related molecule 1A (TL1A) is a vascular endothelial growth inhibitor to reduce neovascularization. Lack of apoE a expression results in hypercholesterolemia and atherosclerosis. In this study, we determined the precise effects of TL1A on
Autor:
Lu-Yuan Li, Xilei Liu, Ya-dan Li, Ruilong Peng, Zhi-tong Zheng, Zilong Zhao, Wei Wei, Shan Gao, Ziwei Zhou, Jianning Zhang
Publikováno v:
Neuroscience. 438
Excessive expression of vascular endothelial growth factor (VEGF) is a common cause of blood-brain barrier (BBB) breakdown that triggers severe complications following traumatic brain injury (TBI). It has been shown that inhibition of VEGF activities